ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Hill's Pet Nutrition, Inc. provides pet food products and pet care services. It offers products to the breeders, veterinarians, and pet supply retailers. The company was founded by Mark L. Morris in 1939 and is headquartered in Topeka, KS.

Hadasit is the technology transfer company of Hadassah Medical Center in Jerusalem. They transform the cutting-edge research coming out of Hadassah into marketable medical technologies. They turn ground-breaking ideas into viable products and services that can change the world and better humanity. For more than a century, Hadassah has set the standard of excellence for medical care and research in Israel. Their doctors and scientists are on the frontlines, uniquely positioned to pinpoint ever-evolving medical needs. Their experience and ingenuity has yielded new ideas with huge potential in all areas of medicine, including therapeutics, diagnostic medical devices, and digital health. More than half of all hospital research in Israel is conducted at Hadassah. Hadasit is Hadassah’s vehicle for commercialization of the intellectual property and R&D capabilities developed there. Hadasit holds exclusive rights to every innovation and invention emerging from Hadassah and they are dedicated to bringing these life-saving technologies to the general public.

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Astrogen Co. Ltd. engages in the development of new drugs for intractable neurological diseases. The company was founded in July 2017 and is headquartered in Daegu, South Korea.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Heilongjiang Feihe Dairy Co., Ltd., part of China Feihe Ltd., is a company headquartered in Herbin, China. The firm manufactures a wide range of milk, juice and diary products.

Innara Health, Inc. provides understanding and improvement of neonatal, pediatric, and adult feeding. It offers the FDA-cleared NTrainer System, the first neonatal technology that assesses and develops non-nutritive suck for newborns and infants born prematurely. The company was founded by David Stalling and D. Michael Litscher in 2006 and is headquartered in Olathe, KS.

Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system. The first product for which the Company completed clinical development, Ampyra (dalfampridine) Extended Release Tablets (Ampyra), was approved by the United States Food and Drug Administration (FDA) in January 2010, as a treatment to improve walking in patients with MS. Ampyra is an extended-release tablet formulation of dalfampridine (4-aminopyridine (4-AP)), which was previously referred to as fampridine. Acorda's marketed product, Zanaflex Capsules, is approved by the FDA as a short-acting drug for the management of spasticity.

Guangzhou Ruizhen Regenerative Medicine Technology Co., Ltd., established on 2019-01-31, Business scope includes research and development of biological products(Does not include licensed operations);Stem Cell Drug Development;Stem Cell Technology Research,to develop;Biotechnology Consulting,communication service;Biotechnology Development Services;Health Management Consulting Services(Medical treatment activities subject to approval,Except for psychological counseling,Does not include licensed operations,Projects prohibited by laws and regulations shall not be operated);Medical supplies and equipment retail(Does not contain drugs and medical devices);Import and export(Excluding franchised products);Sales of Biological Products(Does not include licensed operations);Sales of biological diagnostic reagents and kits(Does not include license approval items);Manufacture of stem cell series technical engineering products;Sales of stem cell series technical engineering products;Manufacture of stem cell engineering series products;Sales of stem cell engineering series products;Preparation of cell preparations and related products;Sales of cell preparations and related products;Stem Cell Biotechnology Consulting Services;Stem Cell Biotechnology Transfer Services;Stem Cell Biotechnology Services;collection of stem cells,storage,preparation service(Without umbilical cord blood hematopoietic stem cell collection,storage);Genetic testing and disease screening services;Collection of immune cells,storage,preparation service(Without umbilical cord blood hematopoietic stem cell collection,storage);Technology development of stem cell engineering series products;Research and development of stem cell series technical engineering products

Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Laval, Canada.

Emotiv is a bioinformatics company developing products and research related to the understanding of the human brain using electroencephalography. Its product portfolio includes developments related to interactive television, everyday computer interactions, hands-free control system, smart adaptive environments, art, accessibility design, market research, psychology, learning, medicine, robotics, automotive, transport safety, defense, and security. It is the developer of products such as Mind for research and Mind for insight, EMOTIV is a recognized pioneer and market leader in this field. Their products have won numerous international awards including the Red Dot Award, AutoVision Innovations Award, Australian International Design Awards, Australian Engineering Excellence Awards and Edison Awards. Its community of developers and researchers span over 100 countries. Emotiv was founded in 2011 and is based in San Francisco, California.

IntElect Medical, Inc., an early stage medical device company, develops and commercializes deep brain stimulation (DBS) therapies and technology for patients suffering with disabilities from stroke and traumatic brain injury. The company focuses on developing an implantable neuromodulation system for stroke and traumatic brain injury recovery.

Good health and a happy life is something all people rightly aspire to. They believe everyone on the planet deserves access to quality health care. Finding affordable solutions to today's health care challenges demands cutting-edge science, highly talented and motivated people and above all the ability to innovate. Innovation and continuous improvement are the heartbeat of their company. Their mission is to make health care more affordable, increasing access to important medicines through the provision of high quality small molecule generics, and new biological and new chemical entities.